Loading…

Enhanced prefrontal serotonin 2A receptor signaling in the subchronic phencyclidine mouse model of schizophrenia

Prefrontal serotonin 2A receptors (5‐HT2ARs) have been linked to the pathogenesis and treatment of schizophrenia. Many antipsychotics fully occupy 5‐HT2AR at clinical relevant doses, and activation of 5‐HT2A receptors by lysergic acid diethylamide (LSD) and LSD‐like drugs induces a schizophrenia‐lik...

Full description

Saved in:
Bibliographic Details
Published in:Journal of neuroscience research 2013-05, Vol.91 (5), p.634-641
Main Authors: Santini, Martin A., Ratner, Cecilia, Aznar, Susana, Klein, Anders B., Knudsen, Gitte M., Mikkelsen, Jens D.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4248-ab6353dbc113c4a9a06802201c042b6c623b43008953580d560aaaac03d1dae43
cites cdi_FETCH-LOGICAL-c4248-ab6353dbc113c4a9a06802201c042b6c623b43008953580d560aaaac03d1dae43
container_end_page 641
container_issue 5
container_start_page 634
container_title Journal of neuroscience research
container_volume 91
creator Santini, Martin A.
Ratner, Cecilia
Aznar, Susana
Klein, Anders B.
Knudsen, Gitte M.
Mikkelsen, Jens D.
description Prefrontal serotonin 2A receptors (5‐HT2ARs) have been linked to the pathogenesis and treatment of schizophrenia. Many antipsychotics fully occupy 5‐HT2AR at clinical relevant doses, and activation of 5‐HT2A receptors by lysergic acid diethylamide (LSD) and LSD‐like drugs induces a schizophrenia‐like psychosis in humans. Subchronic phencyclidine (PCP) administration is a well‐established model for schizophrenia‐like symptoms in rodents. The aim of the present study was to investigate whether subchronic PCP administration changes expression, binding, or functionality of cortical 5‐HT2ARs. As a measure of 5‐HT2AR functionality, we used the 5‐HT2AR agonist 2,5‐dimethoxy‐4‐iodoamphetamine (DOI)‐induced head‐twitch response (HTR) and mRNA expression of the immediate‐early genes (IEGs) activity‐related cytoskeletal associated‐protein (Arc), c‐fos, and early growth response protein 2 (egr‐2) in the frontal cortex. Mice were treated with PCP (10 mg/kg) or saline for 10 days, followed by a 5‐day washout period. The PCP pretreatment increased the overall induction of HTR and frontal cortex IEG mRNA expression following a single challenge with DOI. These functional changes were not associated with changes in 5‐HT2AR binding. Also, binding of the 5‐HT1AR and the 5‐HT transporter was unaffected. Finally, basal mRNA level of Arc was increased in the prefrontal cortex after subchronic PCP administration as revealed with in situ hybridization. Together these findings indicate that PCP administration produces changes in the brain that result in an increase in the absolute effect of DOI. Therefore, neurotransmission involving the 5‐HT2AR could contribute to the behavioral deficits observed after PCP treatment. © 2013 Wiley Periodicals, Inc.
doi_str_mv 10.1002/jnr.23198
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1434033394</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1434033394</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4248-ab6353dbc113c4a9a06802201c042b6c623b43008953580d560aaaac03d1dae43</originalsourceid><addsrcrecordid>eNqNkUFv1DAQhS0EokvhwB9AlrjAIe3Y4zjJsV2V0qpqRQXiaDmOt_GStYOdCJZfj9tte0CqhA_jw3zvyX6PkLcMDhgAP1z7eMCRNfUzsmDQVIUoRfWcLAAlFAIY3yOvUloDQNOU-JLscRQgRIMLMp74XntjOzpGu4rBT3qgycYwBe885Uc0WmPHKUSa3I3Xg_M3NC-m3tI0t6bPEmfo2FtvtmZwnfOWbsKcbmdnBxpWNJne_QljH613-jV5sdJDsm_u733y7dPJ1-Xn4uLq9Gx5dFEYwUVd6FZiiV1rGEMjdKNB1sA5MAOCt9JIjq1AgDp_qKyhKyXofAxgxzptBe6TDzvfMYafs02T2rhk7DBob_PzFBM5A0Rs_gNFJqFErGVG3_-DrsMccyx3VCWaGkuWqY87ysSQUs5VjdFtdNwqBuq2MZUbU3eNZfbdvePcbmz3SD5UlIHDHfDLDXb7tJM6v7x-sCx2Cpcm-_tRoeMPJSusSvX98jSLj6-_lMeNWuJfHG6uXQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1317498351</pqid></control><display><type>article</type><title>Enhanced prefrontal serotonin 2A receptor signaling in the subchronic phencyclidine mouse model of schizophrenia</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Santini, Martin A. ; Ratner, Cecilia ; Aznar, Susana ; Klein, Anders B. ; Knudsen, Gitte M. ; Mikkelsen, Jens D.</creator><creatorcontrib>Santini, Martin A. ; Ratner, Cecilia ; Aznar, Susana ; Klein, Anders B. ; Knudsen, Gitte M. ; Mikkelsen, Jens D.</creatorcontrib><description>Prefrontal serotonin 2A receptors (5‐HT2ARs) have been linked to the pathogenesis and treatment of schizophrenia. Many antipsychotics fully occupy 5‐HT2AR at clinical relevant doses, and activation of 5‐HT2A receptors by lysergic acid diethylamide (LSD) and LSD‐like drugs induces a schizophrenia‐like psychosis in humans. Subchronic phencyclidine (PCP) administration is a well‐established model for schizophrenia‐like symptoms in rodents. The aim of the present study was to investigate whether subchronic PCP administration changes expression, binding, or functionality of cortical 5‐HT2ARs. As a measure of 5‐HT2AR functionality, we used the 5‐HT2AR agonist 2,5‐dimethoxy‐4‐iodoamphetamine (DOI)‐induced head‐twitch response (HTR) and mRNA expression of the immediate‐early genes (IEGs) activity‐related cytoskeletal associated‐protein (Arc), c‐fos, and early growth response protein 2 (egr‐2) in the frontal cortex. Mice were treated with PCP (10 mg/kg) or saline for 10 days, followed by a 5‐day washout period. The PCP pretreatment increased the overall induction of HTR and frontal cortex IEG mRNA expression following a single challenge with DOI. These functional changes were not associated with changes in 5‐HT2AR binding. Also, binding of the 5‐HT1AR and the 5‐HT transporter was unaffected. Finally, basal mRNA level of Arc was increased in the prefrontal cortex after subchronic PCP administration as revealed with in situ hybridization. Together these findings indicate that PCP administration produces changes in the brain that result in an increase in the absolute effect of DOI. Therefore, neurotransmission involving the 5‐HT2AR could contribute to the behavioral deficits observed after PCP treatment. © 2013 Wiley Periodicals, Inc.</description><identifier>ISSN: 0360-4012</identifier><identifier>EISSN: 1097-4547</identifier><identifier>DOI: 10.1002/jnr.23198</identifier><identifier>PMID: 23404493</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>AIDS-Related Complex - genetics ; AIDS-Related Complex - metabolism ; Amphetamines - pharmacology ; Analysis of Variance ; Animals ; Autoradiography ; Disease Models, Animal ; Gene Expression Regulation - drug effects ; Gene Expression Regulation - physiology ; Genes, Immediate-Early - genetics ; immediate early genes ; Male ; Mice ; Mice, Inbred C57BL ; N-methyl-D-aspartate ; Phencyclidine - pharmacology ; Phencyclidine - toxicity ; prefrontal cortex ; Prefrontal Cortex - drug effects ; Prefrontal Cortex - metabolism ; Proto-Oncogene Proteins c-fos - genetics ; Proto-Oncogene Proteins c-fos - metabolism ; Receptors, Serotonin, 5-HT2 - metabolism ; RNA, Messenger - metabolism ; schizophrenia ; Schizophrenia - chemically induced ; Schizophrenia - pathology ; Serotonin Receptor Agonists - pharmacology ; serotoninergic receptors ; Signal Transduction - drug effects ; Time Factors</subject><ispartof>Journal of neuroscience research, 2013-05, Vol.91 (5), p.634-641</ispartof><rights>Copyright © 2013 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4248-ab6353dbc113c4a9a06802201c042b6c623b43008953580d560aaaac03d1dae43</citedby><cites>FETCH-LOGICAL-c4248-ab6353dbc113c4a9a06802201c042b6c623b43008953580d560aaaac03d1dae43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23404493$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Santini, Martin A.</creatorcontrib><creatorcontrib>Ratner, Cecilia</creatorcontrib><creatorcontrib>Aznar, Susana</creatorcontrib><creatorcontrib>Klein, Anders B.</creatorcontrib><creatorcontrib>Knudsen, Gitte M.</creatorcontrib><creatorcontrib>Mikkelsen, Jens D.</creatorcontrib><title>Enhanced prefrontal serotonin 2A receptor signaling in the subchronic phencyclidine mouse model of schizophrenia</title><title>Journal of neuroscience research</title><addtitle>J. Neurosci. Res</addtitle><description>Prefrontal serotonin 2A receptors (5‐HT2ARs) have been linked to the pathogenesis and treatment of schizophrenia. Many antipsychotics fully occupy 5‐HT2AR at clinical relevant doses, and activation of 5‐HT2A receptors by lysergic acid diethylamide (LSD) and LSD‐like drugs induces a schizophrenia‐like psychosis in humans. Subchronic phencyclidine (PCP) administration is a well‐established model for schizophrenia‐like symptoms in rodents. The aim of the present study was to investigate whether subchronic PCP administration changes expression, binding, or functionality of cortical 5‐HT2ARs. As a measure of 5‐HT2AR functionality, we used the 5‐HT2AR agonist 2,5‐dimethoxy‐4‐iodoamphetamine (DOI)‐induced head‐twitch response (HTR) and mRNA expression of the immediate‐early genes (IEGs) activity‐related cytoskeletal associated‐protein (Arc), c‐fos, and early growth response protein 2 (egr‐2) in the frontal cortex. Mice were treated with PCP (10 mg/kg) or saline for 10 days, followed by a 5‐day washout period. The PCP pretreatment increased the overall induction of HTR and frontal cortex IEG mRNA expression following a single challenge with DOI. These functional changes were not associated with changes in 5‐HT2AR binding. Also, binding of the 5‐HT1AR and the 5‐HT transporter was unaffected. Finally, basal mRNA level of Arc was increased in the prefrontal cortex after subchronic PCP administration as revealed with in situ hybridization. Together these findings indicate that PCP administration produces changes in the brain that result in an increase in the absolute effect of DOI. Therefore, neurotransmission involving the 5‐HT2AR could contribute to the behavioral deficits observed after PCP treatment. © 2013 Wiley Periodicals, Inc.</description><subject>AIDS-Related Complex - genetics</subject><subject>AIDS-Related Complex - metabolism</subject><subject>Amphetamines - pharmacology</subject><subject>Analysis of Variance</subject><subject>Animals</subject><subject>Autoradiography</subject><subject>Disease Models, Animal</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Gene Expression Regulation - physiology</subject><subject>Genes, Immediate-Early - genetics</subject><subject>immediate early genes</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>N-methyl-D-aspartate</subject><subject>Phencyclidine - pharmacology</subject><subject>Phencyclidine - toxicity</subject><subject>prefrontal cortex</subject><subject>Prefrontal Cortex - drug effects</subject><subject>Prefrontal Cortex - metabolism</subject><subject>Proto-Oncogene Proteins c-fos - genetics</subject><subject>Proto-Oncogene Proteins c-fos - metabolism</subject><subject>Receptors, Serotonin, 5-HT2 - metabolism</subject><subject>RNA, Messenger - metabolism</subject><subject>schizophrenia</subject><subject>Schizophrenia - chemically induced</subject><subject>Schizophrenia - pathology</subject><subject>Serotonin Receptor Agonists - pharmacology</subject><subject>serotoninergic receptors</subject><subject>Signal Transduction - drug effects</subject><subject>Time Factors</subject><issn>0360-4012</issn><issn>1097-4547</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqNkUFv1DAQhS0EokvhwB9AlrjAIe3Y4zjJsV2V0qpqRQXiaDmOt_GStYOdCJZfj9tte0CqhA_jw3zvyX6PkLcMDhgAP1z7eMCRNfUzsmDQVIUoRfWcLAAlFAIY3yOvUloDQNOU-JLscRQgRIMLMp74XntjOzpGu4rBT3qgycYwBe885Uc0WmPHKUSa3I3Xg_M3NC-m3tI0t6bPEmfo2FtvtmZwnfOWbsKcbmdnBxpWNJne_QljH613-jV5sdJDsm_u733y7dPJ1-Xn4uLq9Gx5dFEYwUVd6FZiiV1rGEMjdKNB1sA5MAOCt9JIjq1AgDp_qKyhKyXofAxgxzptBe6TDzvfMYafs02T2rhk7DBob_PzFBM5A0Rs_gNFJqFErGVG3_-DrsMccyx3VCWaGkuWqY87ysSQUs5VjdFtdNwqBuq2MZUbU3eNZfbdvePcbmz3SD5UlIHDHfDLDXb7tJM6v7x-sCx2Cpcm-_tRoeMPJSusSvX98jSLj6-_lMeNWuJfHG6uXQ</recordid><startdate>201305</startdate><enddate>201305</enddate><creator>Santini, Martin A.</creator><creator>Ratner, Cecilia</creator><creator>Aznar, Susana</creator><creator>Klein, Anders B.</creator><creator>Knudsen, Gitte M.</creator><creator>Mikkelsen, Jens D.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>201305</creationdate><title>Enhanced prefrontal serotonin 2A receptor signaling in the subchronic phencyclidine mouse model of schizophrenia</title><author>Santini, Martin A. ; Ratner, Cecilia ; Aznar, Susana ; Klein, Anders B. ; Knudsen, Gitte M. ; Mikkelsen, Jens D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4248-ab6353dbc113c4a9a06802201c042b6c623b43008953580d560aaaac03d1dae43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>AIDS-Related Complex - genetics</topic><topic>AIDS-Related Complex - metabolism</topic><topic>Amphetamines - pharmacology</topic><topic>Analysis of Variance</topic><topic>Animals</topic><topic>Autoradiography</topic><topic>Disease Models, Animal</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Gene Expression Regulation - physiology</topic><topic>Genes, Immediate-Early - genetics</topic><topic>immediate early genes</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>N-methyl-D-aspartate</topic><topic>Phencyclidine - pharmacology</topic><topic>Phencyclidine - toxicity</topic><topic>prefrontal cortex</topic><topic>Prefrontal Cortex - drug effects</topic><topic>Prefrontal Cortex - metabolism</topic><topic>Proto-Oncogene Proteins c-fos - genetics</topic><topic>Proto-Oncogene Proteins c-fos - metabolism</topic><topic>Receptors, Serotonin, 5-HT2 - metabolism</topic><topic>RNA, Messenger - metabolism</topic><topic>schizophrenia</topic><topic>Schizophrenia - chemically induced</topic><topic>Schizophrenia - pathology</topic><topic>Serotonin Receptor Agonists - pharmacology</topic><topic>serotoninergic receptors</topic><topic>Signal Transduction - drug effects</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Santini, Martin A.</creatorcontrib><creatorcontrib>Ratner, Cecilia</creatorcontrib><creatorcontrib>Aznar, Susana</creatorcontrib><creatorcontrib>Klein, Anders B.</creatorcontrib><creatorcontrib>Knudsen, Gitte M.</creatorcontrib><creatorcontrib>Mikkelsen, Jens D.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of neuroscience research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Santini, Martin A.</au><au>Ratner, Cecilia</au><au>Aznar, Susana</au><au>Klein, Anders B.</au><au>Knudsen, Gitte M.</au><au>Mikkelsen, Jens D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Enhanced prefrontal serotonin 2A receptor signaling in the subchronic phencyclidine mouse model of schizophrenia</atitle><jtitle>Journal of neuroscience research</jtitle><addtitle>J. Neurosci. Res</addtitle><date>2013-05</date><risdate>2013</risdate><volume>91</volume><issue>5</issue><spage>634</spage><epage>641</epage><pages>634-641</pages><issn>0360-4012</issn><eissn>1097-4547</eissn><abstract>Prefrontal serotonin 2A receptors (5‐HT2ARs) have been linked to the pathogenesis and treatment of schizophrenia. Many antipsychotics fully occupy 5‐HT2AR at clinical relevant doses, and activation of 5‐HT2A receptors by lysergic acid diethylamide (LSD) and LSD‐like drugs induces a schizophrenia‐like psychosis in humans. Subchronic phencyclidine (PCP) administration is a well‐established model for schizophrenia‐like symptoms in rodents. The aim of the present study was to investigate whether subchronic PCP administration changes expression, binding, or functionality of cortical 5‐HT2ARs. As a measure of 5‐HT2AR functionality, we used the 5‐HT2AR agonist 2,5‐dimethoxy‐4‐iodoamphetamine (DOI)‐induced head‐twitch response (HTR) and mRNA expression of the immediate‐early genes (IEGs) activity‐related cytoskeletal associated‐protein (Arc), c‐fos, and early growth response protein 2 (egr‐2) in the frontal cortex. Mice were treated with PCP (10 mg/kg) or saline for 10 days, followed by a 5‐day washout period. The PCP pretreatment increased the overall induction of HTR and frontal cortex IEG mRNA expression following a single challenge with DOI. These functional changes were not associated with changes in 5‐HT2AR binding. Also, binding of the 5‐HT1AR and the 5‐HT transporter was unaffected. Finally, basal mRNA level of Arc was increased in the prefrontal cortex after subchronic PCP administration as revealed with in situ hybridization. Together these findings indicate that PCP administration produces changes in the brain that result in an increase in the absolute effect of DOI. Therefore, neurotransmission involving the 5‐HT2AR could contribute to the behavioral deficits observed after PCP treatment. © 2013 Wiley Periodicals, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>23404493</pmid><doi>10.1002/jnr.23198</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0360-4012
ispartof Journal of neuroscience research, 2013-05, Vol.91 (5), p.634-641
issn 0360-4012
1097-4547
language eng
recordid cdi_proquest_miscellaneous_1434033394
source Wiley-Blackwell Read & Publish Collection
subjects AIDS-Related Complex - genetics
AIDS-Related Complex - metabolism
Amphetamines - pharmacology
Analysis of Variance
Animals
Autoradiography
Disease Models, Animal
Gene Expression Regulation - drug effects
Gene Expression Regulation - physiology
Genes, Immediate-Early - genetics
immediate early genes
Male
Mice
Mice, Inbred C57BL
N-methyl-D-aspartate
Phencyclidine - pharmacology
Phencyclidine - toxicity
prefrontal cortex
Prefrontal Cortex - drug effects
Prefrontal Cortex - metabolism
Proto-Oncogene Proteins c-fos - genetics
Proto-Oncogene Proteins c-fos - metabolism
Receptors, Serotonin, 5-HT2 - metabolism
RNA, Messenger - metabolism
schizophrenia
Schizophrenia - chemically induced
Schizophrenia - pathology
Serotonin Receptor Agonists - pharmacology
serotoninergic receptors
Signal Transduction - drug effects
Time Factors
title Enhanced prefrontal serotonin 2A receptor signaling in the subchronic phencyclidine mouse model of schizophrenia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T12%3A42%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Enhanced%20prefrontal%20serotonin%202A%20receptor%20signaling%20in%20the%20subchronic%20phencyclidine%20mouse%20model%20of%20schizophrenia&rft.jtitle=Journal%20of%20neuroscience%20research&rft.au=Santini,%20Martin%20A.&rft.date=2013-05&rft.volume=91&rft.issue=5&rft.spage=634&rft.epage=641&rft.pages=634-641&rft.issn=0360-4012&rft.eissn=1097-4547&rft_id=info:doi/10.1002/jnr.23198&rft_dat=%3Cproquest_cross%3E1434033394%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4248-ab6353dbc113c4a9a06802201c042b6c623b43008953580d560aaaac03d1dae43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1317498351&rft_id=info:pmid/23404493&rfr_iscdi=true